Zipnosis, a years-emerging health-technology firm that allows medical providers to conduct economical "virtual" visits with patients, has raised $17 million in its first formal round of venture capital.
The Minneapolis-based company touts itself the first "virtual care solution" that enables health systems to launch their own "branded" virtual-care clinics online or mobile with their own medical professionals in timely consultations designed to help patients treat themselves, pursue an in-clinic visit or seek other medical help, as their conditions necessitate.
"We've pioneered virtual care as a [software] platform and we're raising the money to try and cement that position," Zipnosis CEO Jon Pearce said last week. "We're about 30 people today and we're going to scale up, double our staff fairly quickly, sales and marketing."
The $17 million round closed recently and will be announced Monday. .
It was led by venture-investor Safeguard Scientifics of Pennsylvania, with funding also from Ascension Ventures, a subsidiary of the nation's largest Catholic health care system. Minneapolis-based Fairview Health Services, Hyde Park Venture Partners, Arthur Ventures, Waterline Ventures and Omphalos Venture Partners, which earlier had made smaller investments that totaled about $3 million, also participated in the first formal round of equity capital.
Zipnosis produces a "white label" software platform that allows outfits such as Fairview, Group Health of Seattle and 15 other current health care customers to "care for more patients under their own brand name and without adding staff," Pearce said. "Patients are happier to be 'seen' sooner without having to step outside their home or go to a waiting room."
In a prepared statement, Al Wiegman, a managing director at Safeguard Scientifics who will join the board of Zipnosis, said: "Virtual visits are an increasingly popular way for clinicians to diagnose and treat patients … and we have the potential to produce better patient outcomes through more rigorous clinical protocols. We're excited to partner with Zipnosis and support its disruptive platform as it works to expand affordable access to health care."
Zipnosis, founded six years ago, struggled as it first tried to launch the product as a direct-to-consumer diagnosis service that didn't involve a medical center in the conversation.